MTLS$5.59
$5.63
Chart
Performance
Key Stats
AI MTLS Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyMaterialise NV shows a mixed profile. Fundamentally sound with growth potential, but technicals are mixed and the thematic impact is moderate. A balanced approach is recommended.
Thematic
Materialise operates in the 3D printing and medical software space, which has growth potential but faces competition and regulatory considerations. The company's focus on medical applications is a strong point.
Fundamental
Materialise demonstrates solid revenue growth and a healthy balance sheet with decreasing debt. Profitability has improved, with positive net income in recent periods.
Technical
Technical indicators show mixed signals. Moving averages suggest a bullish trend, but oscillators indicate potential overbought conditions or neutral momentum across various timeframes.
| Factor | Score |
|---|---|
| Additive Manufacturing Adoption | 70 |
| Medical Technology Advancement | 85 |
| Software & Digitalization Trends | 75 |
| Industry Competition | 50 |
| Regulatory Environment (Medical) | 60 |
| Factor | Score |
|---|---|
| Valuation | 45 |
| Profitability | 65 |
| Growth | 60 |
| Balance Sheet Health | 85 |
| Cash Flow | 60 |
| Factor | Score |
|---|---|
| Trend Analysis | 70 |
| Momentum | 60 |
| Volume Confirmation | 65 |
| Short-term Oscillators | 55 |
| Support & Resistance | 70 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Reasonable P/E Ratio
The Price-to-Earnings (P/E) ratio of 30.18 is reasonable given the company's earnings per share (EPS) of 0.19 and its position in the tech industry.
Positive Short-Term Performance
The stock has shown positive performance over the last 1 month (4.46%) and 5 days (0.61%), indicating recent investor interest.
Bearish Points (7)
Negative Long-Term Performance
The stock has experienced significant declines over the last 6 months (-24.54%) and year-to-date (-19.11%), suggesting weakness in investor sentiment and stock price.
High P/E Ratio for Recent Performance
The P/E ratio of 30.18, while potentially justifiable in some tech sectors, seems high considering the negative net income in 2022 and the relatively modest net margin in 2024.
Calendar
July 2025
24
Next Earnings Date
H: $0.02
A: $0.02
L: $0.02
H: 67.41M
A: 67.20M
L: 67.00M
Profile
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Seasonals
Price Target
9.31 USD
The 39 analysts offering 1 year price forecasts for MTLS have a max estimate of 10.24 and a min estimate of 8.38.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
A direct and major competitor to Materialise, offering a broad portfolio of 3D printing hardware, software, and services, with significant overlap in medical and industrial applications.
Weight: 93
A primary competitor in industrial 3D printing hardware and services, especially in polymer-based systems, vying for market share and technological advancements with Materialise.
Weight: 88
A direct competitor in the industrial 3D printing service bureau space, specializing in large-format binder jetting technology for sand and plastic parts.
Weight: 85
A key player in metal additive manufacturing, expanding its presence through acquisitions (like ExOne), offering technologies that complement or compete with Materialise's software and services for metal printing.